Abstract
The Human Orthopneumovirus, also known as Human Respiratory Syncytial Virus, is responsible for several hospital admissions of children, the elderly and immunosuppressed people due to complications of the lower respiratory tract. Currently, there is no specific and financially accessible treatment. Furthermore, available vaccines don't cover all risk groups. Our research group has investi…